Hola,

Welcome to the work from home edition of our newsletter. To start, here’s a market map of the tech that’s helping us WFH. 

As in past crises, the world may go back to “normal” one day, but it won’t look quite the same (remember what airport security was like before 9/11?). And it’s safe to say there will be a lot more remote work happening. Would you agree that distributed work will become an essential part of the mix rather than an option?

And for the kids...

If you are like many of us, reality has set in that home-schooling for young children is not going away any time soon. Running out of ideas? We put together a guide for CBI parents — check it out here.

Cybersecurity stronger than the Cybertruck
 

The Covid-19 crisis is underscoring the importance of cybersecurity as teams go fully remote. 
 

We talk about cyber-risks in our 2020 Tech Trends report here.

Out of office
 

Enterprise collaboration tools like Slack, Zoom, and Atlassian are seeing skyrocketing use amid the pandemic.
 

Take a look at 65+ startups enabling remote work here.

Link up

Companies across biopharma, academia, tech, and more are establishing partnerships to fight new pathogens.

From Apple partnering with the CDC to Pfizer with Biontech, clients can take a look at key partnerships aimed at diagnosing and treating Covid-19 here.

We recently published the annual AI 100, our list of the 100 most promising AI startups in the world. Healthcare was the most heavily featured category in our list and is the top industry for AI deal activity at large. 

Since publishing, a number of companies on the list have been working to combat and contain Covid-19. Startups like DarwinAI and Eko are facilitating faster and more precise diagnosis, while Atomwise and Cyclica are using AI to discover potential drug compound candidates to fight the virus.

7 of the companies in the cohort have struck new deals since publishing, the most recent being AI systems developer 4Paradigm. The company raised $85M in a second tranche of its Series C last week and is now valued at $2B. 4Paradigm has recently shifted to develop solutions for precision screening and contact sourcing of Covid-19.

 See how other AI startups are developing systems to predict and track infectious disease outbreaks.

Have a great rest of the week.

P.S. Sign up for early access to our PwC/CB Insights MoneyTree report here, in which we'll cover how venture funding has been hit by Covid-19.